Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
9481
-
9482
Numerically simulated GRAPPA-accelerated acquisitions of a phantom.
Published 2016“…<p>Random coil noise was added to the 50 scan average described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163618#pone.0163618.g001" target="_blank">Fig 1C</a>) for the conventional T<sub>2</sub>-Prep as well as for 2D-T<sub>2</sub>-Prep modules of radius 6.0 and 12.0 cm. …”
-
9483
R″→T transition for a single subunit of GroEL.
Published 2009“…The end states refer to subunit A in the PDB structures 1GRU and 1GR5. Results are shown for <i>F<sub>min</sub></i> = 0.4, 0.5, 0.6 and 0.7, corresponding to the allowable angular deviations of up to 50.8°, 45.0°, 39.2° and 33.2°, respectively, between and <i>v</i><i><sub>A</sub></i><sup>(<i>k</i>)</sup> (or <i>v</i><i><sub>B</sub></i><sup>(<i>k</i>)</sup>). …”
-
9484
Splicing assays of wt and mutant pre-mRNA in the absence and presence of wild-type StpA and mutant G126V-StpA
Published 2011“…The reactions were performed in the presence of 5 mM MgCl, 0.5 mM GTP, 50 mM Tris–HCl (pH 7.3) and 0.4 mM spermidine (see Materials and Methods). () Splicing of the wt intron pre-RNA without added protein (full circles), with the addition of 1.4 μM wild-type StpA (full squares) or 1.4 μM G126V-StpA mutant (empty squares). () Splicing of the C865U pre-RNA intron mutant without protein (full circles), with addition of 1.4 μM wild-type StpA (full squares) or 1.4 μM G126V-StpA mutant (empty squares). …”
-
9485
-
9486
Temperature: A major climatic determinant of cowpea production
Published 2022“…Thus, the objective of this study was to evaluate the influence of water availability and temperature on the performance of cowpea cultivars. A greenhouse experiment was conducted using a 4 × 2 × 5 factorial arrangement, with four replications. …”
-
9487
Involvement of p38MAPK activation in IL-17A-mediated hypercontractility in primary cultured murine SI SMCs.
Published 2014“…SB203580 (SB, 1 µM), BIRB796 (BIRB, 10 nM), SP600125 (JNK II, 100 nM) and JNK inhibitor III (JNK III, 100 nM) were added 15 min before addition of IL-17A (50 ng/ml). Contractility was measured as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0092960#pone-0092960-g006" target="_blank">Fig. 6A</a> (n = 8). …”
-
9488
-
9489
Image_5_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9490
Table_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.DOCX
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9491
Image_4_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9492
Image_3_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9493
Image_2_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9494
Image_1_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf
Published 2019“…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
-
9495
A regulatory gene network of foam-cell formation.
Published 2008“…CE accumulation (given as average percentage next to each node) was decreased (blue) by siRNA inhibition of 5 genes and increased (red) by inhibition of 2 genes; inhibition of 1 gene had no effect (black) (see also <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000036#pgen-1000036-t003" target="_blank">Table 3</a>). …”
-
9496
Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway
Published 2019“…Esculetin significantly inhibited proliferation of HCC cells in a concentration- and time-dependent manner and with an IC50 value of 2.24 mM. …”
-
9497
-
9498
-
9499
-
9500